What is the treatment for Diabetic Ketoacidosis (DKA) in a 75 kg patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Diabetic Ketoacidosis in a 75 kg Patient

For a 75 kg patient with DKA, begin immediate fluid resuscitation with 0.9% NaCl at 1125-1500 mL/hour for the first hour, followed by continuous IV regular insulin at 7.5 units/hour (0.1 units/kg/hour) without an initial bolus, while aggressively monitoring and replacing potassium to maintain levels between 4-5 mEq/L. 1

Initial Fluid Resuscitation

  • Start with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour during the first hour, which translates to 1125-1500 mL/hour for this 75 kg patient to restore intravascular volume and renal perfusion 1
  • After the initial hour, switch to 0.45% NaCl at 4-14 mL/kg/hour (300-1050 mL/hour) if corrected serum sodium is normal or elevated; continue 0.9% NaCl if corrected sodium is low 1
  • Balanced electrolyte solutions may be considered as an alternative to 0.9% saline, as they have shown faster DKA resolution in some studies 1, 2

Insulin Therapy Protocol

  • Start continuous IV regular insulin at 0.1 units/kg/hour (7.5 units/hour for this 75 kg patient) WITHOUT an initial bolus 1, 2
  • If plasma glucose does not fall by 50 mg/dL from the initial value in the first hour, double the insulin infusion every hour until achieving a steady glucose decline of 50-75 mg/hour 3, 2
  • When plasma glucose reaches 250 mg/dL, decrease insulin infusion to 0.05-0.1 units/kg/hour (3.75-7.5 units/hour) and add 5-10% dextrose to IV fluids 3
  • Never interrupt insulin infusion when glucose falls—instead add dextrose-containing fluids (5% dextrose with 0.45-0.75% NaCl) to maintain glucose 150-200 mg/dL while continuing insulin to clear ketosis 1

Critical Potassium Management

  • Check potassium level immediately—if K+ <3.3 mEq/L, DELAY insulin therapy until potassium is repleted to >3.3 mEq/L to prevent life-threatening arrhythmias and cardiac arrest 1, 2
  • Once K+ is <5.5 mEq/L and renal function is assured, add 20-40 mEq/L potassium to IV fluids (2/3 KCl and 1/3 KPO4) 1, 2
  • Target serum potassium 4-5 mEq/L throughout treatment 1, 2

Bicarbonate Therapy (Generally NOT Recommended)

  • Bicarbonate is generally not recommended for pH >6.9, as studies show no benefit on clinical outcomes and potential harm including worsening ketosis, hypokalemia, and cerebral edema risk 1, 2
  • Consider bicarbonate ONLY if pH <6.9: give 100 mmol sodium bicarbonate in 400 mL sterile water at 200 mL/hour 1, 2
  • For pH 6.9-7.0, give 50 mmol sodium bicarbonate in 200 mL sterile water at 200 mL/hour 2

Monitoring Protocol

  • Check blood glucose every 1-2 hours 1, 2
  • Draw blood every 2-4 hours for electrolytes, glucose, BUN, creatinine, osmolality, and venous pH 1, 2
  • Venous pH (typically 0.03 units lower than arterial pH) and anion gap can be followed instead of repeated arterial blood gases 1, 2
  • Continuous cardiac monitoring is crucial to detect arrhythmias early, especially given the risk of electrolyte-induced cardiac complications 2

Resolution Criteria

DKA is resolved when ALL of the following are met 1, 2:

  • Glucose <200 mg/dL
  • Bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Anion gap ≤12 mEq/L

Transition to Subcutaneous Insulin

  • Administer subcutaneous basal insulin (intermediate or long-acting) 2-4 hours BEFORE stopping IV insulin to prevent rebound ketoacidosis and hyperglycemia 1, 2
  • For newly diagnosed patients, initiate approximately 0.5-1.0 units/kg/day (37.5-75 units/day for this 75 kg patient) as a multidose regimen of short- and intermediate/long-acting insulin 3, 2

Identify and Treat Precipitating Causes

  • Obtain cultures (blood, urine, throat) and start antibiotics if infection suspected 1, 2
  • Review medications—SGLT2 inhibitors can cause euglycemic DKA and should be discontinued 1, 2
  • Search for myocardial infarction, stroke, or other acute stressors 2

Common Pitfalls to Avoid

  • Premature termination of insulin therapy before complete resolution of ketosis—continue insulin until all resolution criteria are met, not just glucose normalization 1, 4
  • Starting insulin before correcting severe hypokalemia (K+ <3.3 mEq/L)—this can precipitate fatal arrhythmias 1, 2
  • Stopping IV insulin without prior subcutaneous basal insulin administration—this causes rebound ketoacidosis 1, 2
  • Relying on nitroprusside method to measure ketones—this doesn't detect β-hydroxybutyrate, the predominant ketone body in DKA; direct β-hydroxybutyrate measurement is preferred 4, 2
  • Correcting osmolality too rapidly—induced change in serum osmolality should not exceed 3 mOsm/kg/hour to prevent cerebral edema 2

References

Guideline

Management of Severe DKA with Profound Metabolic Acidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Euglycemic Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.